Common and Specific Information From Neuroimaging and Smartphone
Recruiting · NCT05482906 · Observational (researchers observe without assigning treatment) · Lead sponsor: Nantes University Hospital
View the official record on ClinicalTrials.gov →Interventions studied
eGait
What this trial is about
Gait alteration is frequent in MS and limitation in walking ability is a major concern in MS patients. Umanit and LMJL (Nantes university) has developed a device call egait to assess walking ability in individuals (eg MS patients).
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Diagnosis of MS based on McDonald criteria (including Relapsing-remitting and progressive MS)
- Over 18 years old /age greater than 18 years
- Patients followed at Nantes university hospital or Rennes university hospital
- Last known EDSS before inclusion ranging from 0 to 6 inclusive/EDSS of 0 to 6 inclusive, prior inclusion
- No relapse within 3 months
- With a Medullar MRI planed as part as usual care
- MRI scan can be performed within a maximum of 4 months after or before the walking test.
- Affiliated person or beneficiary of a social security scheme
Exclusion criteria
- Bilateral aid needed to walk
- Women who are pregnant
- Patient having expressed their opposition
- Patient under guardianship or security measure
Where it is running
1 location listed.
- Nantes University Hospital - Nantes, Loire-Atlantique, France